NCT06507436

The Phase III Clinical Study of Herombopag for the Treatment of Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery

← 임상시험 허브

레지스트리 요약

진행 상태: 완료 (COMPLETED)
질환/조건: Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery
시험 유형: 중재 연구 (INTERVENTIONAL)
단계: Phase 3
목적: 치료
중재 유형: 약물
개입·치료: Herombopag tablets, Herombopag placebo tablets
Lead Sponsor: Jiangsu HengRui Medicine Co., Ltd. (산업계)

캐시 시각: 2026-08-28 23:27:15

ClinicalTrials.gov에서 보기

요약

This study includes Part A and Part B. Part A is a dose-finding study for subjects with chronic liver disease-related thrombocytopenia scheduled for elective surgery. Part B is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical study designed to evaluate the efficacy and safety of Herombopag compared to placebo in patients with chronic liver disease-related thrombocytopenia undergoing elective invasive surgery.

문의

이 시험 기반 리포트·메디컬라이팅이 필요하시면 문의해 주세요.

리포트 문의 메디컬라이팅 문의 맞춤 리서치 리포트